Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CENTENE CORPORATION

(CNC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Centene : Mizuho Securities Adjusts Centene PT to $67 From $75, Maintains Neutral Rating

09/08/2021 | 09:20am EDT


ę MT Newswires 2021
All news about CENTENE CORPORATION
10/27Morgan Stanley Adjusts Price Target on Centene to $86 from $79, Keeps Overweight Rating
MT
10/27Credit Suisse Lifts Centene's PT to $75 from $70, Says Modest Growth Better Than Expect..
MT
10/26Wall Street Poised for a Positive Open; Futures Green, Europe Higher
MT
10/26Centene Q3 Adjusted Earnings, Revenue Top Street Estimates
MT
10/26CENTENE : Q3 Earnings Snapshot
AQ
10/26CENTENE CORPORATION REPORTS THIRD QUARTER 2021 RESULTS - Form 8-K
PU
10/26Centene Corporation Reports Earnings Results for the Third Quarter and Nine Months Ende..
CI
10/26CENTENE CORP : Results of Operations and Financial Condition, Financial Statements and Exh..
AQ
10/26CENTENE CORP Management's Discussion and Analysis of Financial Condition and Results o..
AQ
10/26GUIDANCE : (CNC) CENTENE CORPORATION Forecasts Fiscal Year 2021 EPS Range $5.05 - $5.15
MT
More news
Analyst Recommendations on CENTENE CORPORATION
More recommendations
Financials (USD)
Sales 2021 126 B - -
Net income 2021 1 161 M - -
Net Debt 2021 9 280 M - -
P/E ratio 2021 36,1x
Yield 2021 -
Capitalization 41 166 M 41 166 M -
EV / Sales 2021 0,40x
EV / Sales 2022 0,39x
Nbr of Employees 71 300
Free-Float 95,9%
Chart CENTENE CORPORATION
Duration : Period :
Centene Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CENTENE CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 70,55 $
Average target price 84,42 $
Spread / Average Target 19,7%
EPS Revisions
Managers and Directors
Michael F. Neidorff Chairman & Chief Executive Officer
Brent Davis Layton President & Chief Operating Officer
Andrew Lynn Asher Chief Financial Officer & Executive Vice President
Mary V. Mason Chief Medial Officer & Senior Vice President
Ken Yamaguchi Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
CENTENE CORPORATION17.52%41 166
UNITEDHEALTH GROUP29.65%427 594
ANTHEM, INC.35.86%105 261
CIGNA CORPORATION3.60%72 579
HUMANA INC.13.85%58 937
MOLINA HEALTHCARE, INC.39.00%17 264